AtaiBeckley Inc. (ATAI)
ATAI moved a median of -0.21% 30 minutes after news, and -0.40% by the close. How ATAI actually reacts to news — the realized, point-in-time move the market made, measured across 303 labeled events over the last three years with zero look-ahead.
ATAI’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.16% | 44% | 288 |
| 30-min | -0.21% | 43% | 288 |
| 60-min | -0.35% | 42% | 288 |
| to close | -0.40% | 46% | 284 |
| Middle 50% of ATAI reactions | -2.57% to +1.67% |
|---|---|
| Median reaction (30-min) | -0.21% |
| Measured reactions | 303 |
Half of all AtaiBeckley Inc. news events land between -2.57% and +1.67% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How ATAI reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 19 | +0.07% | 58% | +0.56% |
| Coverage initiations | 13 | -0.10% | 31% | -1.14% |
| Rating reiterations | 29 | +0.49% | 55% | +0.94% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 1 further class was observed with fewer than 10 measured events and is not published. See how ATAI ranks against every other measured name →
That’s how ATAI usually reacts — get an email when it moves on news →Email me when ATAI moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ATAI's baseline. Nothing else.
Recent ATAI events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Are DSGR, HLX, ATAI, CRNX Obtaining Fair Deals for their Shareholders? | Press release | PR Newswire | +0.21% | +0.69% | |
| Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders? | Press release | PR Newswire | +0.00% | +0.07% | |
| ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly | Press release | GlobeNewswire | +0.21% | +0.14% | |
| Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? | Press release | PR Newswire | +0.00% | -0.42% | |
| Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time | Press release | Canada Newswire | +0.64% | +1.98% | |
| Are ATAI, FHB, PATK Obtaining Fair Deals for their Shareholders? | Press release | PR Newswire | +0.64% | +1.98% | |
| ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether AtaiBeckley Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | -0.67% | +0.88% | |
| AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder | Press release | GlobeNewswire | +3.06% | -2.17% | |
| AtaiBeckley to Join the Russell Indexes, Expanding Visibility Across U.S. Equity Markets | Press release | GlobeNewswire | +5.18% | +10.36% | |
| AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations | Press release | GlobeNewswire | -0.23% | +2.56% | |
| AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026 | Press release | GlobeNewswire | -1.28% | +0.70% | |
| AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update | Press release | GlobeNewswire | +0.25% | +2.98% | |
| AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research | Press release | GlobeNewswire | +0.33% | -5.65% | |
| AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs | Press release | GlobeNewswire | -0.26% | -3.09% | |
| AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst | Press release | GlobeNewswire | -0.15% | +0.30% | |
| BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on Track for Q2 2026 Initiation | Press release | GlobeNewswire | -0.28% | +0.83% | |
| BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day | Press release | GlobeNewswire | +0.26% | +7.81% | |
| CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions | Press release | PR Newswire | +0.95% | +5.28% | |
| AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update | Press release | GlobeNewswire | +1.41% | -1.74% | |
| AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression | Press release | GlobeNewswire | -1.08% | -0.27% | |
| Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments | Press release | PR Newswire | +0.00% | +2.40% | |
| AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder | Press release | GlobeNewswire | -2.18% | -4.36% | |
| AtaiBeckley To Host Virtual Investor Day on March 6, 2026 | Press release | GlobeNewswire | +1.30% | +1.30% | |
| AtaiBeckley Appoints Michael Faerm as Chief Financial Officer | Press release | GlobeNewswire | -5.19% | -3.29% | |
| AtaiBeckley To Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +4.62% | +3.26% | |
| AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation | Press release | GlobeNewswire | -1.34% | -2.15% | |
| AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference | Press release | GlobeNewswire | -0.23% | -0.75% | |
| Form 15-12G Atai Beckley N.V. | SEC filing · Form 15-12G | SEC EDGAR | -0.75% | +2.76% | |
| Form POSASR Atai Beckley N.V. | SEC filing · Form POSASR | SEC EDGAR | -0.75% | +2.76% | |
| Form S-8 POS Atai Beckley N.V. | SEC filing · Form S-8 | SEC EDGAR | -0.75% | +2.76% | |
| AtaiBeckley Completes Redomiciliation to the United States | Press release | GlobeNewswire | -0.75% | +2.76% | |
| AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) | Press release | GlobeNewswire | +1.72% | -1.14% | |
| AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio | Press release | GlobeNewswire | +0.69% | +1.61% | |
| Form 8-K Atai Beckley N.V. For: Dec 05 | SEC filing · Form 8-K | SEC EDGAR | +0.23% | +1.60% | |
| Enhanced Fortifies Executive Leadership Team & Board of Directors | Press release | PR Newswire | +2.57% | -5.91% | |
| AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London | Press release | GlobeNewswire | +0.69% | — | |
| AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | +0.35% | +0.46% | |
| Form 10-Q Atai Beckley N.V. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.69% | — | |
| Form 8-K Atai Beckley N.V. For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | +0.35% | +0.46% | |
| AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression | Press release | GlobeNewswire | -2.97% | -4.40% | |
| atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies | Press release | GlobeNewswire | +0.10% | -13.18% | |
| Form 8-K ATAI Life Sciences N.V. For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | +0.10% | -13.18% | |
| Form 8-K ATAI Life Sciences N.V. For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | +0.10% | -13.18% | |
| Form 8-K ATAI Life Sciences N.V. For: Oct 23 | SEC filing · Form 8-K | SEC EDGAR | +1.53% | +5.78% | |
| Form 8-K ATAI Life Sciences N.V. For: Oct 20 | SEC filing · Form 8-K | SEC EDGAR | -2.00% | -9.69% | |
| atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares | Press release | GlobeNewswire | -2.38% | -9.69% | |
| Form 8-K ATAI Life Sciences N.V. For: Oct 16 | SEC filing · Form 8-K | SEC EDGAR | -1.81% | -3.31% | |
| atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression | Press release | GlobeNewswire | +5.41% | +16.22% | |
| atai Life Sciences Announces Pricing of Public Offering of Common Shares | Press release | GlobeNewswire | +5.41% | +16.22% | |
| atai Life Sciences Announces Proposed Public Offering of Common Shares | Press release | GlobeNewswire | +5.41% | +16.22% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ATAI section they belong to.
Where else ATAI is measured.
ATAI earnings → · Analyst actions → · SEC filings →
Other Consumer Defensive names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Central Garden & Pet Company (CENT) | 311 | +0.12% | 57% |
| Flowers Foods, Inc. (FLO) | 309 | -0.09% | 44% |
| Boston Beer Company, Inc. (The) (SAM) | 303 | +0.05% | 52% |
| SpartanNash Company (SPTN) | 301 | -0.08% | 34% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Consumer Defensive names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is AtaiBeckley Inc.'s median reaction calculated?
Every labeled ATAI news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 303 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 43% of ATAI's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ATAI's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.